Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In a 111-person group of people treated for HIV, the average viral reservoir half-life was 12 years.
The antibody VRC01 proved safe but didn’t do a stellar job of delaying HIV’s rebound after stopping standard antiretroviral treatment.
“I’m so tired of people complaining that I haven’t found ‘the cure’ for HIV,” writes Pia Wurtzbach on Instagram.
A second man may have been cured of HIV following treatment for leukemia and a stem-cell transplant.
A cure and a vaccine are topics of research supported by the 2016 Mathilde Krim Fellowships.
An experimental treatment based on a Crohn’s disease drug has led to sustained viral remission without additional treatment in monkeys.
Researchers have identified 170 children living with HIV who maintain near-normal immune function without treatment.
The misreported news, which originated in The Sunday Times, concerns a “kick-and-kill” cure attempt that still requires years of follow-up...
Scientists have created a consortium to help them better understand and potentially achieve a cure based on stem cell transplants.
Plus, the BEAT-HIV Delaney project spells out its “three research pillars.”
Even when HIV is fully suppressed, such viral activity may spur persistent immune activation and complicate cure attempts.
A roundup of the major presentations on HIV science at the international conference held July 22 to 28 outlines many exciting developments.
Starting HIV meds within 15 days of infection prevented the development of antibodies.
Investigators have created a consortium hoping to yield HIV cures through stem cell transplants like the ones that cured the Berlin Patient.
Treatment with vorinostat, hydroxychloroquine and maraviroc had no effect on viral rebound after an HIV treatment interruption.
The injectable antibody 3BNC117 suppressed HIV and delayed viral rebound for up to 19 weeks in people with the virus who stopped their meds.